Acquisition

RNS Number : 7239I

Intertek Group PLC

09 July 2013

 



Stock Exchange Release

9 July 2013, 7.00am London, UK

Intertek announces new acquisition extending its Pharmaceutical Services

Intertek Group plc (Intertek), a leading quality solutions provider to industries worldwide, announces that it has acquired Melbourn Scientific Ltd (Melbourn), a specialist pharmaceutical products testing business.

Melbourn is a privately owned UK company based near Cambridge, a heartland of the UK's pharma and biotech industry. It employs over 80 expert scientists and staff and reported £4 million of revenue in 2012.

The company has built a strong reputation over the last 24 years providing expert testing and formulation services to the international pharmaceutical industry, with focus on the testing and evaluation of nasally and orally inhaled drugs and their delivery systems such as inhalers and nebulisers.

This continues to be a fast growing sector of the industry as pharmaceutical and biotechnology companies continue to search for alternative delivery systems for current and next generation drugs.

Wolfhart Hauser, Chief Executive Officer of Intertek, commented: 

"We are pleased to welcome this group of highly respected scientists to Intertek which extends the portfolio of capabilities within our Pharmaceutical Services business in the important and growing area of alternative drug delivery methods. By combining our expertise in physical characterisation of medicinal compounds and drug to device interaction with Melbourn's specialist capabilities, we have an unrivalled offering to our clients."

-ends-

Contacts

Aston Swift, Intertek  Telephone: [phone]     

[e-mail]

Richard Mountain, FTI Consulting  Telephone: [phone]

[e-mail]

About Intertek

Intertek is a leading quality solutions provider to industries worldwide.  From auditing and inspection, to testing, training, advisory, quality assurance and certification, Intertek adds value to customers' products, processes and assets.  With a network of more than 1,000 laboratories and offices and over 35,000 people in more than 100 countries, Intertek supports companies' success in a global marketplace. Intertek helps its customers to meet end users' expectations for safety, sustainability, performance, integrity and desirability in virtually any market worldwide.  Visit www.intertek.com

 

END

 

 

ACQEAAXSEDXDEFF